Qorvo Biotechnologies Awarded $4.1 Million National Institutes of Health Contract for SARS-CoV-2/ Flu Combo and Antigen Pooling
ソース:
Nasdaq GlobeNewswire
/
07 2 2022 08:00:00 America/New_York
N/A
シェアする